These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7690741)

  • 1. HLA-DR beta chain residues that are predicted to be located in the floor of the peptide-binding groove contribute to antibody-binding epitopes.
    Klohe E; Fu XT; Ballas M; Karr RW
    Hum Immunol; 1993 May; 37(1):51-8. PubMed ID: 7690741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR residues accessible under the peptide-binding groove contribute to polymorphic antibody epitopes.
    Fu XT; Drover S; Marshall WH; Karr RW
    Hum Immunol; 1995 Aug; 43(4):243-50. PubMed ID: 7499171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DR alpha chain residues located on the outer loops are involved in nonpolymorphic and polymorphic antibody-binding epitopes.
    Fu XT; Karr RW
    Hum Immunol; 1994 Apr; 39(4):253-60. PubMed ID: 7520896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse locations of amino acids in HLA-DR beta chains involved in polymorphic antibody binding epitopes on DR(alpha, beta 1*0101), DR(alpha, beta 1*1101), and DR(alpha,beta 3*0202) molecules.
    Fu XT; Klohe E; Alber C; Yu WY; Ferrara GB; Pistillo MP; Ballas M; Karr RW
    Hum Immunol; 1992 Mar; 33(3):193-201. PubMed ID: 1377667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide.
    Fu XT; Bono CP; Woulfe SL; Swearingen C; Summers NL; Sinigaglia F; Sette A; Schwartz BD; Karr RW
    J Exp Med; 1995 Mar; 181(3):915-26. PubMed ID: 7869051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of an HLA-DRw52-associated determinant on DR beta 1 molecules.
    Ballas M; Eiermann TH; Wölpl A; Goldmann SF
    Tissue Antigens; 1990 Nov; 36(5):187-93. PubMed ID: 1710076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role of HLA-DR beta 1 residue 58 in multiple polymorphic epitopes recognized by xenogeneic and allogeneic antibodies.
    Klohe E; Pistillo MP; Ferrara GB; Goeken NE; Greazel NS; Karr RW
    Hum Immunol; 1992 Sep; 35(1):18-28. PubMed ID: 1282512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of residues involved in polymorphic antibody binding epitopes on HLA-DR molecules.
    Fu XT; Yu WY; Alber C; Benson C; Watts R; Nordwig H; Johnson JP; Knowles RW; Karr RW
    Hum Immunol; 1992 Jan; 33(1):47-56. PubMed ID: 1372304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acids in the peptide-binding groove influence an antibody-defined, disease-associated HLA-DR epitope.
    Drover S; Marshall WH; Kwok WW; Nepom GT; Karr RW
    Scand J Immunol; 1994 Jun; 39(6):539-50. PubMed ID: 7516571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
    Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Freidel C; Gebuhrer L; Betuel H; Borras-Cuesta F; Sterkers G
    J Immunol; 1993 Dec; 151(11):6237-47. PubMed ID: 7504016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvariation creates significant functional differences in the DR3 molecules.
    Posch PE; Araujo HA; Creswell K; Praud C; Johnson AH; Hurley CK
    Hum Immunol; 1995 Jan; 42(1):61-71. PubMed ID: 7751161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple regions of HLA-DR beta 1 chains determine polymorphic epitopes recognized by monoclonal antibodies.
    Alber CA; Watts R; Klohe EP; Drover S; Marshall WH; Radka SF; Karr RW
    J Immunol; 1989 Oct; 143(7):2248-55. PubMed ID: 2476501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acidic residues in the DR beta chain third hypervariable region are required for stimulation of a DR(alpha, beta 1*0402)-restricted T-cell clone.
    Olson RR; Reuter JJ; McNicholl J; Alber C; Klohe E; Callahan K; Siliciano RF; Karr RW
    Hum Immunol; 1994 Nov; 41(3):193-200. PubMed ID: 7868374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphic HLA-DR7 beta 1 chain residues that are involved in T cell allorecognition.
    Rosen-Bronson S; Yu WY; Karr RW
    J Immunol; 1991 Jun; 146(12):4264-70. PubMed ID: 2040801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope mapping of an HLA-DR-specific monoclonal antibody produced by using human-mouse transfectant cells.
    Madrigal JA; Ikeda H; Marsh SG; Heyes JM; Kennedy LJ; Trowsdale J; Bodmer JG
    J Immunol; 1989 Dec; 143(12):4084-9. PubMed ID: 2480386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfer of polymorphic monoclonal antibody epitopes to the first and second domains of HLA-DR beta-chains by site-directed mutagenesis.
    Maurer D; Gorski J
    J Immunol; 1991 Jan; 146(2):621-6. PubMed ID: 1702809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR and -DQ epitopes and monoclonal antibody specificity.
    Marsh SG; Bodmer JG
    Immunol Today; 1989 Sep; 10(9):305-12. PubMed ID: 2480137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New polymorphic HLA-DR epitopes recognized by three monoclonal antibodies produced against DR103 transfected L cells.
    Cayrol C; Moro F; Sommer E; Tkaczuk J; Ohayon E; Cambon-Thomsen A
    Tissue Antigens; 1992 Oct; 40(4):197-203. PubMed ID: 1281933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-B*0702 antibody epitopes are affected indirectly by distant antigen residues.
    McCutcheon JA; Smith KD; Valenzuela A; Aalbers K; Lutz CT
    Hum Immunol; 1993 Feb; 36(2):69-75. PubMed ID: 7681814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional activity of staphylococcal enterotoxin A requires interactions with both the alpha and beta chains of HLA-DR.
    Dowd JE; Karr RW; Karp DR
    Mol Immunol; 1996 Nov; 33(16):1267-74. PubMed ID: 9129163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.